Patents Assigned to Merck Patents GmbH
  • Publication number: 20150071953
    Abstract: The present invention relates to the preparation and use of recombinant variants of group 6 allergens of the Poaceae (true grasses), which are characterised by reduced IgE reactivity compared with known wild-type allergens and at the same time substantially retained reactivity with T-lymphocytes.
    Type: Application
    Filed: November 18, 2014
    Publication date: March 12, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Martin WALD, Andreas NANDY, Helmut FIEBIG, Bernhard WEBER, Helga KAHLERT, Gerald REESE, Oliver CROMWELL
  • Publication number: 20150070628
    Abstract: The present invention relates to electro-optical switching elements and displays comprising them. In particular, it relates to electro-optical switching elements comprising at least a light reflecting layer, a light switching layer, and a light conversion layer, which comprises one or more light emitting substances, in particular, a light reflecting layer, which selectively reflects visible light, a light controlling element that controls the amount of transmitted and/or reflected light, and a light converting layer that shifts the wavelength of the transmitted light to longer values. The displays give bright images under either bright or dark conditions with small power consumption. They are particularly suitable for so called liquid crystal, electronic paper (e-paper) and MEMS switching applications.
    Type: Application
    Filed: April 3, 2013
    Publication date: March 12, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Masayoshi Suzuki, Naoya Fujiwara
  • Publication number: 20150069304
    Abstract: The invention relates to novel fullerene derivatives, to methods for their preparation and educts or intermediates used therein, to mixtures and formulations containing them, to the use of the fullerene derivatives, mixtures and formulations as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising, or being prepared from, these fullerene derivatives, mixtures or formulations.
    Type: Application
    Filed: September 11, 2014
    Publication date: March 12, 2015
    Applicants: Nano-C, Inc., MERCK PATENT GMBH
    Inventors: Nicolas BLOUIN, Stephane BERNY, Edward A. JACKSON, Henning RICHTER, Feng HE
  • Publication number: 20150069287
    Abstract: The present invention relates to thermally conductive pigments which consist of a substrate and a coating applied thereto comprising aluminium oxide and/or aluminium oxide hydrate, to a process for the preparation of these pigments, and to the use thereof.
    Type: Application
    Filed: March 5, 2013
    Publication date: March 12, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Reinhold Rueger, Matthias Kuntz
  • Publication number: 20150068979
    Abstract: The present invention relates to a holder for monolithic sorbents in which a radial pressure can be exerted over the entire length of the sorbent by a conically tapering clamping tube.
    Type: Application
    Filed: March 22, 2013
    Publication date: March 12, 2015
    Applicant: Merck Patent GmbH
    Inventors: Karin Cabrera Perez, Klaus Kreher, Willi Neuroth, Michael Ukelis
  • Publication number: 20150070609
    Abstract: The present invention relates to a liquid crystal (LC) medium comprising a polymerizable compound, to a process for its preparation, to its use for optical, electro-optical and electronic purposes, in particular in an LC display, especially in an LC display of the PSA (“polymer sustained alignment”) type, and to an LC display comprising the LC medium.
    Type: Application
    Filed: September 11, 2014
    Publication date: March 12, 2015
    Applicant: Merck Patent GmbH
    Inventors: Eveline BARON, Julian VOGT, Qiong TONG, Stephan DEROW
  • Patent number: 8974702
    Abstract: The present invention relates to novel formulations comprising an organic semiconductor (OSC) and one or more organic solvents. The formulation comprises a dimethyl anisole solvent. Furthermore, the present invention describes the use of these formulations as inks for the preparation of organic electronic (OE) devices, especially organic photovoltaic (OPV) cells and OLED devices, to methods for preparing OE devices using the novel formulations, and to OE devices, OLED devices and OPV cells prepared from such methods and formulations.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: March 10, 2015
    Assignee: Merck Patent GmbH
    Inventors: Philip Edward May, Mark James, Susanne Heun, Magda Goncalves-Miskiewicz, Katie Court
  • Patent number: 8975619
    Abstract: The invention relates to co-activated silicate based phosphors. The invention further relates to the method of preparing these phosphors and to the use of these phosphors in electronic and electrooptical devices, in particular in light emitting diodes (LEDs) and solar cells. The invention further relates to illumination units comprising said phosphors.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: March 10, 2015
    Assignee: Merck Patent GmbH
    Inventors: Hiroshi Okura, Takeo Wakimoto, Koutoku Ohmi, Yoshinobu Miyamoto
  • Patent number: 8975512
    Abstract: Tandem photovoltaic cells having a recombination layer, as well as related systems, methods, and components, are disclosed.
    Type: Grant
    Filed: June 18, 2013
    Date of Patent: March 10, 2015
    Assignee: Merck Patent GmbH
    Inventors: Christoph Brabec, Russell Gaudiana, Christoph Waldauf
  • Patent number: 8974693
    Abstract: The present invention relates to a liquid-crystalline medium, characterized in that it contains a polymerizable component (A) containing one more polymerizable compounds and a liquid-crystalline component (B) containing one more compounds of the general formula I in which R, rings A1 and A2, Z1, Z2, Y1, Y2, X0 and r are as defined in Claim 1.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: March 10, 2015
    Assignee: Merck Patent GmbH
    Inventors: Seung-Eun Lee, Eun Young Kim, Dong-Mee Song, Kyung-Ah Park, Sang-Hyun Park, Eun-Kyu Lee
  • Publication number: 20150065644
    Abstract: This invention relates to polymer particles for use in electrowetting fluids and electrowetting displays devices comprising such particles.
    Type: Application
    Filed: February 25, 2013
    Publication date: March 5, 2015
    Applicant: Merck Patent GmbH
    Inventors: Louise D. Farrand, Nathan Smith, Roshan Kumar, Claire Topping
  • Patent number: 8968840
    Abstract: The present invention relates to a liquid-crystalline medium based on a mixture of polar compounds having negative dielectric anisotropy (??), which is distinguished by the fact that it has a value for the ratio ?1/?n2 in the range 6-45 with a clearing point of >60° C. and a ?? of ??2.3. Media of this type are particularly suitable for electro-optical displays having active-matrix addressing based on the ECB, PA LCD, FFS or IPS effect.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: March 3, 2015
    Assignee: Merck Patent GmbH
    Inventors: Melanie Klasen-Memmer, Sabine Schoen
  • Patent number: 8969508
    Abstract: Photoactive polymers are provided, as well as related photovoltaic cells, articles, systems, and methods comprising these photoactive polymers.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: March 3, 2015
    Assignee: Merck Patent GmbH
    Inventors: Li Wen, David P. Waller, Paul Byrne, Nicolas Drolet, Gilles Herve Regis Dennler, Kap-Soo Cheon
  • Patent number: 8969335
    Abstract: Compounds of the formula I, in which R1, R2, X and Y have the meanings indicated in Claim 1, are inhibitors of TBK1 and IKK? and can be employed, inter alia, for the treatment of cancer and inflammatory diseases.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: March 3, 2015
    Assignee: MERCK PATENT GmbH
    Inventors: Guenter Hoelzemann, Dieter Dorsch, Hans-Michael Eggenweiler
  • Patent number: 8969318
    Abstract: Disclosed are bispecific aptamers binding with high specifity to a tumour specific antigen (TSA) and a effector cell specific antigen (ESA) for treatment of cancer.
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: March 3, 2015
    Assignee: Merck Patent GmbH
    Inventors: Lars Toleikis, Ralf Guenther, Bjoern Hock, Achim Doerner
  • Patent number: 8969512
    Abstract: The present invention relates to polymers which contain at least one carbazole structural unit of the general formula (I) where Ar1, Ar2, Ar3 is each, independently of one another, an aryl or heteroaryl group, which may be substituted by one or more radicals R of any desired type; m, o is, independently of one another, 0 or 1; n is 1, 2 or 3 and the dashed lines represent the linking in the polymer; and at least one arylamine structural unit of the general formula (II) and/or (III) where Ar4, Ar5, Ar7, Ar8 is each, independently of one another, an aryl or heteroaryl group, which may be substituted by one or more radicals R of any desired type; Ar6 is an aryl or heteroaryl group, which may be substituted by one or more radicals R of any desired type, or represents a group of the formula Ar9-Y—Ar9, where Ar9 is in each case, independently, an aryl or heteroaryl group, which is substituted by one or more radicals R of any desired type or which may be linked to one another, and Y is a spacer group or a direct bon
    Type: Grant
    Filed: August 1, 2011
    Date of Patent: March 3, 2015
    Assignee: Merck Patent GmbH
    Inventors: Niels Schulte, Anna Hayer, Aurélie Ludemann
  • Publication number: 20150056229
    Abstract: The present invention relates to the provision of a DNA sequence of the major grass pollen allergen Lol p 4. The invention also encompasses fragments, new combinations of partial sequences and point mutants having a hypoallergenic action. The recombinant DNA molecules and the derived polypeptides, fragments, new combinations of partial sequences and variants can be utilised for the therapy of pollen-allergic diseases. The proteins prepared by recombinant methods can be employed for in vitro and in vivo diagnosis of pollen allergies.
    Type: Application
    Filed: November 7, 2014
    Publication date: February 26, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Andreas NANDY, Helmut FIEBIG, Oliver CROMWELL
  • Publication number: 20150057264
    Abstract: Compounds of the formula I in which R1, X and Y have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
    Type: Application
    Filed: March 19, 2013
    Publication date: February 26, 2015
    Applicant: Merck Patent GmbH
    Inventors: Dieter Dorsch, Hans-Peter Buchstaller, Gerard Moinet, Ansgar Wegener
  • Patent number: 8962892
    Abstract: The invention relates to a process for the preparation of tris(perfluoroalkyl)phosphine oxides by reaction of tris(perfluoroalkyl)difluorophosphorane with alkaline-earth metal oxides, alkaline-earth metal carbonates, zinc oxide, copper(I) oxide, copper(II) oxide, silver oxide, mercury(II) oxide, cadmium oxide or cadmium carbonate.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: February 24, 2015
    Assignee: MERCK PATENT GmbH
    Inventors: Nikolai Mykola Ignatyev, Waldemar Wiebe, Helge Willner
  • Patent number: 8962783
    Abstract: Photovoltaic cells with silole-containing polymers, as well as related systems, methods and components are disclosed.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: February 24, 2015
    Assignee: Merck Patent GmbH
    Inventors: Russell Gaudiana, Richard Kingsborough, Xiaobo Shi, David Waller, Zhengguo Zhu